Regulatory Approvals, Merger Control and Cross-Border Risk

CVML

Published on March 25 , 2026

Regulatory approvals are increasingly a central consideration in transactions, particularly those involving cross-border elements.

In the UAE, the evolving merger control regime and broader regulatory landscape mean that parties may need to assess whether approvals are required and how these processes may affect transaction timelines.

Key considerations include:

  • whether merger control filings are required
  • anticipated timelines for regulatory review
  • foreign investment and ownership restrictions
  • potential sanctions or trade-related considerations
  • allocation of regulatory risk between parties

Delays in obtaining regulatory approvals can have a significant impact on deal execution, particularly where transactions are subject to long-stop dates or financing arrangements.

Parties may therefore wish to consider how regulatory risk is allocated within transaction documentation, including which party is responsible for obtaining approvals and whether any obligations are imposed to secure those approvals.

Early assessment of regulatory requirements can help ensure that transaction timelines are realistic and that potential risks are identified and managed effectively.

If you or your organisation would like to discuss any aspect of this guidance note further, please don’t hesitate to reach out to your usual CVML contact, or email:

Naji Khairallah, Partner, CVML (n.khairallah@cvml.ae)